Syndicate This week's upcoming IPO's and secondary offerings

Week of July 24 to July 28, 2024

This Week's Priced Deals

07/24 - Monday

Symbol

Issuer

Type

Price

Managers

SRPT

Sarepta
Sarepta
Secondary
Priced: $42.50
7.65M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Goldman Sachs & Credit Suisse

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/25 - Tuesday

Symbol

Issuer

Type

Price

Managers

RBB

RBB Bancorp
RBB Bancorp
IPO
Priced: $23.00
3.75M
Sandler O'Neill,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Sandler O'Neill, Keefe Bruyette & Stephens, Fig Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MC

Moelis
Moelis
Spot Secondary
Priced: $42.00
6M
Goldman Sachs & JPMorgan

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OEC

Orion Engineered
Orion Engineered
Spot Secondary
Priced: $21.85
10M
Barclays & Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Barclays & Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/26 - Wednesday

Symbol

Issuer

Type

Price

Managers

TRIP

TripAdvisor
TripAdvisor
Block Trade
Priced: $39.00
450K
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SNNA

Sienna Biopharmaceuticals
Sienna Biopharmaceuticals
IPO
Priced: $15.00
4.333M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, TD Cowen & BMO Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FH

FORM Holdings Corp
FORM Holdings Corp
Secondary
Priced: $1.10
6M
Roth MKM

Pre-open pricing

Managers: Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RETA

Reata Pharmaceuticals
Reata Pharmaceuticals
Secondary
Priced: $31.00
3.25M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, Leerink & Stifel, Baird, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CIT

CIT Group
CIT Group
Spot Secondary
Priced: $47.85
2.1M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CUR

Neuralstem
Neuralstem
Spot Secondary
Priced: $2.00
2.25M
Canaccord

Pricing after close
Deal analysis and details

Managers: Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TBK

Triumph Bancorp
Triumph Bancorp
Spot Secondary
Priced: $27.50
2.2M
Stephens,...

Pricing after close
Deal analysis and details

Managers: Stephens, Keefe Bruyette, Sandler O'Neill & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/27 - Thursday

Symbol

Issuer

Type

Price

Managers

RDFN

Redfin
Redfin
IPO
Priced: $15.00
9.231M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Allen & Co., BofA & RBC Capital, Oppenheimer, Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TTPH

Tetraphase
Tetraphase
Secondary
Priced: $6.50
10M
Piper Sandler,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Piper Sandler, BMO Capital, Stifel, Truist & H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATNM

Actinium Pharmaceuticals
Actinium Pharmaceuticals
Spot Secondary
Priced: $.75
16.125M
Oppenheimer

Pricing after close

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KMDA

Kamada
Kamada
Spot Secondary
Priced: $4.50
3.3M
Cantor Fitzgerald,...

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald, Raymond James, Oppenheimer, Ladenburg & Chardan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
WWE

WWE
WWE
Spot Secondary
Priced: $21.00
3.5M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access